RE:RE:Great Q4Just reviewed the financials. Looks like the company has gained some consistency with the last 3 quarters revenue, $2.338, $2.141 and $2.195 million. The last 3 quarters EDITBA $0.274, $0.362 and $0.653 million. If you extrapolate these results over twelve months 1*revenue would be $0.26 and 6*EDITBA would be $0.30. In the past year working capital has gone from -0.5 million to +0.5 million mainly the result of Harris Liontas $1.2 million loan going to long term debt. Mr. Liontas the CEO owns 17% of the shares and continues to support the company financially. Finally with a $3.5 million backlog as of Dec. 31 and New contract wins in 2023 from the US gov't, Eastern Europe, Mexico and the health care sector among others the future of Norva looks much better than last year.